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Abstract 
Background 
Complex healthcare interventions consist of multiple components which may vary in trials 
conducted in different populations and contexts. Pooling evidence from trials in a systematic 
review is challenging because it is unclear which components are needed for effectiveness. 
The potential is recognised for using recipients’ views to explore why some complex 
interventions are effective and others are not. Methods to maximise this potential are poorly 
developed. 
Methods 
We used a novel approach to explore how patients’ views may explain the disparity in 
effectiveness of complex interventions. We used qualitative comparative analysis to explore 
agreement between qualitative syntheses of data on patients’ views and evidence from trialed 
interventions to increase adherence to treatments. We first populated data matrices to reflect 
whether the content of each trialed intervention could be matched with suggestions arising 
from patients’ views. We then used qualitative comparative analysis software to identify, by a 
process of elimination, the smallest number of configurations (patterns) of components that 
corresponded with patients’ suggestions and accounted for whether each intervention was 
effective or ineffective. 
Results 
We found suggestions by patients were poorly represented in interventions. Qualitative 
comparative analysis identified particular combinations of components corresponding with 
patients’ suggestions and with whether an intervention was effective or ineffective. Six 
patterns were identified for an effective and four for an ineffective intervention. Two types of 
patterns arose for the effective interventions, one being didactic (providing clear information 
or instruction) and the other interactive (focusing on personal risk factors). 
Conclusions 
Our analysis highlights how data on patients’ views has the potential to identify key 
components across trials of complex interventions or inform the content of new interventions 
to be trialed. 
Keywords 
Complex interventions, randomised controlled trials, qualitative evidence, qualitative 
comparative analysis 
Background 
Systematic reviews of randomised controlled trial (RCTs) are invaluable in combining 
evidence on effectiveness. Their interpretation is most straightforward in drug therapies. 
However, interpretation of the effectiveness of more complex interventions is challenging as 
the interventions may consist of several components that vary across trials but are assumed to 
contribute to the effect. Based on reasons of practicality or personal choice policy makers and 
planners may then select one of these varying interventions. They may also pick certain 
components contained in one or more of these interventions. New approaches are being 
sought to increase our understanding of how healthcare interventions exert their effects. 
These may involve asking trialists to identify the common components of their effective 
interventions, for example in relation to stroke care units [1]. They may also, based on expert 
consultation using consensus methods and literature review, involve developing taxonomy to 
classify and describe effective interventions [2]. Or they may involve seeking to identify 
mechanisms through which effects of the intervention are achieved. For example, behaviour 
change theory might be applied to trials identified in a systematic review of ‘audit and 
feedback’ interventions [3]. 
Another way is to use recipients’ perspectives, experiences or opinions on the potential 
suitability and utility of an intervention. Recipients’ views are clearly important, particularly 
for interventions that require their active participation. Innovative approaches to using such 
information are being explored, for instance drawing on qualitative evidence on recipients’ 
(usually patients’) views to inform effectiveness evidence from systematic reviews of trials 
[4]. The Cochrane Handbook on Systematic Reviews lists various ways qualitative evidence 
can be used [5]. These include (but are not limited to) helping to define the research question 
and helping to ensure the review includes important outcomes. Another way is to supplement 
reviews by synthesising qualitative evidence within a stand-alone, but complementary, 
quantitative review to address questions on aspects other than effectiveness. In this way it is 
possible to examine whether interventions that address patients’ priorities might be more 
effective than those that do not. If this is shown to be the case, it may be possible to identify 
components that may have more or less influence on outcomes. However, such 
considerations are constrained by the quality, accuracy and extent of descriptions of the 
intervention in papers reporting the results of trials [6,7]. Sometimes, there may be no clear 
description of the intervention beyond a basic statement, for example what telephone 
counseling or psychosocial care involved [7]. In addition, it remains unclear exactly how best 
to bring together within a systematic review the different types of evidence (qualitative and 
quantitative). Moreover, linking qualitative and quantitative evidence may be hampered by 
the usual custom of publishing different kinds of evidence in separate journals. 
In earlier research we used evidence from trials of a complex intervention in which content of 
the intervention was reported and whose overall effect was unclear [8]. This we combined 
with evidence from a review of qualitative studies (often referred to as a qualitative evidence 
synthesis (QES)). We used a data matrix table to align the evidence from the QES of patients’ 
views with the evidence from a Cochrane systematic review of trials. This allowed visual 
exploration of correspondence between (i) suggestions on intervention content derived from 
the QES, and (ii) components of interventions in effective and ineffective trials. We reported 
that components of effective interventions corresponded more often than those of ineffective 
interventions with patients’ priorities derived from the QES. The potential of combining 
mixed evidence in this way is recognised [9]. 
Qualitative comparative analysis (QCA) is an analytical approach and a set of techniques 
[10]. It is recognised in social sciences as an innovation in mixed methods research [11,12], 
and it has been found to be applicable to the evaluation of complex public health 
interventions [13]. QCA has as yet untested potential for use in integrating reviews of 
qualitative and quantitative health evidence [14]. The potential of QCA in the analysis of a 
systematic review of complex interventions is seen in: (1) its usefulness in small datasets 
(where statistical analysis can be limited), and (2) how it seeks to explain a given outcome by 
identifying multiple pathways of putative causal factors. This may be viewed as analogous 
with locating different recipes to make a cake. This approach is relevant to the analysis of 
complex interventions where the focus should include the differing circumstances, 
mechanisms and patterns through which an intervention may fit together to exert its effect. In 
this paper, we report our research using a systematic review with a larger number of quality 
trials than in our earlier work [8]. This allowed us to test the use of QCA in understanding 
how to integrate qualitative and quantitative review evidence. In doing so, we aimed to 
identify more information than would be possible by visual inspection. 
In this worked example of combining mixed evidence from systematic reviews on 
interventions to improve adherence to drug therapy, we used QCA to explore how qualitative 
evidence might explain the variability in effectiveness of complex interventions. 
The objective was to identify matches between patients’ views and components of 
interventions and see whether these matches were associated with the effectiveness of 
interventions. 
Methods 
Data 
We first identified a systematic review of trials. We searched specifically for a Cochrane 
systematic review because these reviews are performed to internationally agreed standards. 
We sought a review on chronic disease self-management because it requires long-term 
commitment by patients, whose views are therefore pertinent. This review needed to involve 
a sufficient number of trials to require an analytical tool to aid quantitative analysis (at least 
five trials) [15]. It also needed to include trials that differed in intervention effect, and in 
which the content of the intervention was described in sufficient detail to understand how the 
intervention might be operationalised in practice. We chose a review of interventions to 
promote adherence to drug therapy for a range of conditions [16], because it fulfilled our 
criteria and because we were aware from earlier work that a complementary QES was 
available [8]. This QES by Vervoort and colleagues explored evidence about HIV/AIDS 
patients’ views on their disease self-management [17]. We purposively sought additional 
QES for adherence to therapy in other common chronic diseases reported in the trials 
included in the Cochrane review (such as diabetes, asthma and depression) [16]. We searched 
three large citation databases from 1999 to 2009; Medline, Psyinfo and Cinahl. We used 
terms relating to the diseases of participants in the trials and terms describing a QES. Details 
of the search strings for identifying QES are listed in Additional file 1. As the focus of this 
study was on the exploratory use of QCA, our search for QES was not exhaustive. We were 
not concerned that we may not identify a QES in relation to patients’ views on all diseases 
relevant to the Cochrane review. This is because our earlier research suggested that such 
evidence was not necessarily disease-specific [8]. We identified three relevant QES [18-20]. 
They were selected on the basis that (1) they explored patients’ views on living or managing 
their chronic disease, (2) they were of sufficient methodological quality [21], and (3) their 
findings were or could be translated into suggestions for strategies to promote adherence to 
therapy for a range of long-term conditions. The QES by Vervoort et al. identified earlier 
thematically analysed evidence from 18 studies on patients views on adherence to HIV 
therapy [17]; of the others, Campbell et al. synthesised evidence in a meta-ethnographic 
review from 10 studies on patients’ views on diabetes including how they managed their 
disease [18], the QES by Malpass and colleagues was a meta-ethnography of 16 studies on 
patients’ experience of taking antidepressants [19] and the other, the QES by Schlomann and 
colleagues , analysed thematically 11 studies on lay beliefs about high blood pressure [20]. 
From each QES one author (BC) extracted data on findings relating to promoting adherence. 
They were listed as individual strategies to promote adherence. The extraction sheet used to 
extract data from the QES is detailed in Additional file 2. Another author (LJ) checked the 
list for completeness against the QES. The final list was discussed with all authors at project 
meetings. From the QES by Vervoort et al. we had already derived 22 suggested strategies 
[17]. The additional three QES provided 17 suggestions; of these, 14 were similar to those 
generated from the QES by Vervoort et al. [17]. They focused on the same issues, for 
example in the QES on beliefs about high blood pressure, the authors derived as an 
implication for practice that: ‘The therapeutic content of that consultation is in part dependent 
on the GP’s understanding of the patients’ beliefs and views regarding medication use’ [20]. 
This is similar to two suggestions from the QES by Vervoort et al , specifically the more 
general suggestion ‘Interventionists should enquire into possible factors influencing each 
individual patient before starting treatment’ and the more focused suggestion advising that 
‘ambivalence towards medications should be discussed’ [17]. In total, we listed 25 different 
ways of promoting adherence. These are listed in Additional file 2: Table S2. 
We did not set methodological quality criteria for selection of the review of trials as we 
assumed a published Cochrane review would have already undergone rigorous checking. 
However our earlier research suggested the need to restrict trials by quality [8]. Therefore, we 
only used the 21 trials that were assessed by the Cochrane reviewers as fulfilling their quality 
criteria [22-42]. This was based on the key recommendation by the Cochrane Collaboration, 
which was assessment of whether randomization was concealed [43]. The 21 trialed 
interventions in our chosen Cochrane review varied in how they aimed to promote adherence, 
for example by providing more instruction, increasing convenience of care, and providing 
psychological therapy and/or group meetings. 
Eleven of the trials were deemed by the Cochrane reviewers as effective in promoting 
adherence. This judgment was based on whether the P value was significant at the <0.05 
level. On this basis we assigned a binary outcome for each of the trials; ‘1’ if the trial was 
effective and ‘0’ if ineffective. We were aware of the weakness of using the P value as 
indicating effect, but additional information was limited. We could not use the preferred 
option of effect size, because some trials did not report this. Trials also assessed adherence 
differently, including pill counts, self-report of adherence and pharmacist records. The data 
extraction form for whether the intervention was found to be effective is provided in 
Additional file 2: Table S3. 
Conjoining extracted data 
We scored the contents of each intervention against the 25 suggested strategies derived from 
the QES. The information on intervention content was key to our analysis. Details of the 
interventions were sought from the original trial papers in which they were more extensively 
reported. However, to ensure detail was sufficient for our analysis, on reading the papers we 
applied two criteria: (1) that more than two sentences were devoted to describing the 
intervention content, and (2) that components were described in detail [44]. What we meant 
by detail was that there was more than a brief statement. For instance, if the intervention was 
described as educational, then there needed to be detail on more than one aspect of that 
educational approach. All intervention descriptions met these criteria. Intervention 
descriptions ranged in length from three sentences to twenty-eight (the median in 
interventions found ineffective was six to eight, and in effective was nine to ten). The 
description for each trial intervention is provided in Additional file 3. We used binary 
scoring; 1 = suggestion corresponded with an intervention component, 0 = no 
correspondence. We were aware that binary scoring could reduce the potential information 
available. However, a more graded scoring was for many suggestions not relevant, and if 
adopted might have increased subjectivity in scoring. To enhance standardisation and clarity, 
scoring guidelines (available from authors) were devised and tested by independent 
researchers. We populated a data matrix table for each intervention with all the conjoined 
data and where the intervention was effective. We report an analysis of the relationships 
created in this table between the qualitative and quantitative data. 
Qualitative comparative analysis: the approach 
To analyse the relationships created we used QCA [10]. QCA uses Boolean algebra. It is 
grounded in set-theoretic relationships. This allows in the analysis all logically possible 
combinations of factors to be examined systematically in relation to the outcome: as in which 
ingredients work together to make a cake. In our worked example, QCA identifies across 
interventions all parsimonious patterns of components that match patients’ views and result in 
the intervention being effective. Here, parsimonious is the smallest number of patterns of 
components (in the dataset) that account for the intervention effect. This is not to imply that 
an intervention is effective because of the match with patients’ views but rather this 
congruence might moderate its effectiveness. 
QCA is case-orientated in that it seeks to explain the outcome in terms of ‘pathways of 
components’ per trialed intervention: as in which ingredients per cake were essential or 
necessary. This differs from a conventional statistical approach, which would average the 
effect simultaneously across all interventions. Therefore, in this example QCA presents ‘key’ 
components per individual intervention. ‘Key’ in these data means those found to be the 
simplest explanation (in the data provided) for the results. 
Qualitative comparative analysis: the technique 
To explore patterns in the relationships between the data we used specific QCA analysis 
software [45]. The software explored these data using Boolean algorithms. This involved 
pair-wise comparison between interventions to establish commonalities in the way the 
relationships created (between the qualitative and quantitative evidence) combined together 
in effective and ineffective interventions. To do this the QCA software reduced the data 
presented per intervention by only retaining those data found to produce the outcome. 
The analytical process has several stages; these are charted in Figure 1. QCA involves 
analysis of cases, factors and outcomes. In these data cases are the interventions and outcome 
is whether or not the intervention under trial conditions was found to be effective. Factors 
were the relationships created between the suggested strategies and the intervention content, 
that is whether or not the intervention contained content that corresponded with patients’ 
views on how to promote adherence. QCA is limited in the number of factors that can be 
included in analysis. This is because cases must be aligned with factors and this process can 
quickly become unwieldy. This is due to the large number of possible combinations of factors 
that are created. For two factors there will be four possible configurations, for nine factors 
there will be 512 and so on. Thus the number of possible configurations of factors can 
quickly exceed the number of cases. On examining published papers using QCA, we found 
that none used more than 10 factors. In our worked example, we reduced our number of 
suggested strategies from 25 by first not including those that had been taken up by three or 
fewer of the trialed interventions. We then combined those that had some overlap in aim. 
This resulted in nine suggested strategies. See Table 1. 
Figure 1 Flow chart for QCA analysis. 
  
Table 1 Reducing for the purposes of qualitative comparative analysis (QCA) the 
number of factors to below 10 
First step. Excluding 10 factors that had been 
described in three or fewer interventions: 
1. Acknowledging within the intervention that adherence is dynamic. 
2. Paying attention to possible negative social circumstances. 
3. Discussing whether secrecy of disclosing condition is threatened by taking 
treatment. 
4. Discussing the seriousness of the disease. 
5. Feedback about positive reactions of the body to treatment should be provided. 
6. In cases of depression, this should be treated before starting therapy; substance 
misuse should be managed as a first priority. 
7. To develop a trusting relationship with the patient. 
8. To facilitate to learn to trust in oneself. 
9. To get patients to describe their own behaviour. 
10. To offer good medical follow-up. 
Second step. Combining factors that had some 
similarity in aim: 
11. Enquire into personal risks factors, and 12. Use insight on personal risk factors 
became ‘a focus on personal risk factors’; 
13. Discuss ambivalence to medicine, and 14. Discuss acceptance of disease became 
‘an exploration of attitudes to drug and/or disease’; 
15. Pointing out the value of treatment to a patient’s life enhances motivation, and 16. 
Explain the relationship between adherence and disease became ‘emphasis on the value 
of adherence’; 
17. Clear instructions on how to take medication, and 18. Information appropriate to 
patient’s understanding became ‘clear or appropriate information’; 
19. Acquire insight into a patient’s social support systems, 20. Counsel patient on how 
use social support, and 21. Social support has to be substantial and practical became ‘a 
focus on improving social support’. 
Final list of factors used in QCA (this is the four 
remaining factors (22 to 25) and the five combined 
factors (a to e) 
22. Discuss circumstances that lead to forgetting to take treatment. 
23. Emphasise that experiencing no symptoms does not mean to stop taking the drug. 
24. Enhance convenience of taking the drug. 
25. Information on side effects. 
a. A focus on personal risk factors. 
b. An exploration of attitudes to drug and/or disease. 
c. Emphasis on the value of adherence. 
d. Clear or appropriate information. 
e. A focus on improving social support. 
QCA analysis is unidirectional; therefore we undertook two analyses, one for effective and a 
second for ineffective interventions. 
Analysis models 
QCA uses three analysis models to summarise findings [10]. These are the complex, 
intermediate and the parsimonious. We present the parsimonious model because, unlike the 
complex model, it fully utilises the mathematical approach by allowing inferences to be made 
on unobserved cases. Inferences are based on the patterns found between the data in the 
observed cases; the model makes assumptions on the outcome of the combinations of factors 
not taken up in the unobserved cases. In the complex model, no inferences are made on 
unobserved cases. In a sensitivity analysis, we also ran the analysis using this model. In the 
intermediate model, the researcher makes assumptions on unobserved cases by testing the 
effect in one selected direction only (as in a one-tailed statistical test). We did not use this 
model as a suggested strategy could have potentially led to a negative outcome. 
Sensitivity analysis 
Our approach involved subjective decisions that could impact on our findings. Therefore, we 
tested the underlying assumptions in our model by: 
• reducing data by (1) excluding cases (interventions) if they did not correspond with any of 
the suggestions (factors); and (2) removing certain suggestions because they did not enter the 
final analysis model or were found in analysis to explain the outcome by both their presence 
or their absence; 
• increasing the data by including all 67 trialed interventions (irrespective of quality) in the 
Cochrane review; 
• analysing the data differently by (1) reporting the results using the QCA complex model; 
and (2) using (where appropriate) a graded scoring system rather than binary to score 
agreement between intervention components and suggestions. 
Results 
We found that suggestions by patients were poorly represented in interventions. In Additional 
file 4 this is illustrated in a cell by a ‘–’. QCA identified six potential pathways 
(configurations of components) to an effective and four to an ineffective intervention. The 
configurations are different per outcome. Each configuration is represented in Additional file 
4 by a different colour shading, border or cell pattern. 
Effective interventions 
There were two types of patterns for the effective interventions; one involving the presence of 
one component (pathway 1), and the others involving more components of which some are 
shared between the configurations (pathways 2 to 6). 
The configuration most commonly associated with effectiveness (found in eight trials) 
involved one component: ‘a focus on personal risk factors’ (pathway 1: [22-
24,26,27,30,33,34]). Other configurations each involved either the presence of ‘explaining 
the value of adherence’ or ‘provision of clear/appropriate information on how to take 
medication’, and the absence of other components (Table 2 and Additional file 4: Table S1). 
  
Table 2 Pathways identified to effective and ineffective interventions 
Effective 
interventions 
The configuration most commonly associated with effectiveness (found in 
eight trials) involved one factor: ‘a focus on personal risk factors’ (pathway 
1: [15-17,19,20,23,26,27]). Other configurations each involved the presence 
of one factor, and the absence of other factors. One configuration involved 
‘explaining the value of adherence’ with the absence of: 
(i) ‘Discuss circumstances that lead to forgetting to take treatment’ and ‘a 
focus on improving social support’ (pathway 2: [24,25,29]). 
Or the absence of: 
(i) ‘Discussion relating to not stopping the medication if there are no 
symptoms’ and ‘improving social support’ (pathway 3: [16,18,22,29]). 
The other configurations involved ‘provision of clear/appropriate information 
on how to take medication’, with the absence of: 
(i) ‘Exploration of attitudes to therapy/disease’ and ‘discussion relating to not 
stopping taking medication if there are no symptoms’ (pathway 
4:[17,18,22,29]). 
Or the absence of: 
(ii) ‘Discussion relating to missing a drug’ and ‘discussion relating to not 
stopping taking medication if there are no symptoms’ (pathway 5: 
[24,25,27,29]). 
Or the absence of: 
(iii) ‘Discussion relating to not stopping taking medication if there are no 
symptoms’ and ‘improving social support’ (pathway 6: [17,18,22,29]). 
Ineffective 
interventions 
All four configurations (pathways) for the ineffective interventions included 
the absence of one factor: ‘a focus on personal risk factors’. Two of the 
configurations also involved the absence of either: 
(i) ‘Information on side effects’ and ‘pointing out the value of adherence’ 
(pathway 1: [31,33-35]). 
or 
(ii) ‘Pointing out the value of adherence’ and ‘provision of clear or 
appropriate information’ (pathway 2: [30,33-35]). 
In the other two configurations the absence of ‘a focus on personal risk 
factors’ also involved the presence of either: 
(i) ‘Discussion relating to missing a drug’ (pathway 3: [28,30-32]). or 
(ii) ‘Emphasis that experiencing no symptoms does not mean stopping 
medication’ (pathway 4: [21,32]). 
The pathways correspond with two distinct approaches to promoting adherence, one being 
interactive (‘a focus on personal risk factors’) (pathway 1) and the other more didactic 
(‘emphasizing clear or appropriate information’) (pathways 2 to 6). Neither the interactive 
nor the didactic approach was differently associated with the specific diseases in the trial 
populations. 
Ineffective interventions 
All four configurations (pathways) for the ineffective interventions included the absence of 
one component, ‘a focus on personal risk factors’. The configurations also involved various 
combinations of other components (Table 2 and Additional file 4: Table S2). 
Sensitivity analyses 
There were sufficient data to undertake all proposed sensitivity analyses. None of the 
analyses had dramatically different findings, in that most of the dominant patterns per 
outcome remained. A common component, ‘a focus on personal risk factors’, for an effective 
intervention remained in most analyses. As before, the configurations for ineffective 
interventions commonly remained the mirror opposites of those found in the models for an 
effective outcome. As expected, the sensitivity analyses produced more configurations. Some 
of these (particularly when all trials irrespective of quality were included) were conflicting, in 
that they included per outcome both the presence and absence of certain factors. 
Discussion 
Main findings 
We tested QCA as a way to combine QES evidence on patients’ views with evidence from a 
systematic review of trials of a complex intervention. We used as a worked case example 
evidence on interventions to promote adherence to long-term drug therapy. We found in 
general, patients’ suggestions on what is important were poorly represented in the 
interventions. Using QCA we found that certain suggestions seemed to hold together in 
particular patterns that corresponded to whether the intervention was effective or not. Three 
influential components were identified in the effective interventions, while other components 
were influential through their absence. It seemed that those that were influential by their 
absence were those in which those providing the intervention focused on negative influences 
on adherence, such as ‘the need to take the drug continuously irrespective of symptoms’. The 
pattern of components suggests two approaches to promoting adherence. One involved 
adopting an interactive style focusing on personal risk factors. The other was a more didactic 
approach. This involved emphasising clear, appropriate information including the value of 
adherence but without discussing certain potentially challenging aspects, such as discussion 
of attitudes to medication or disease, missing doses or enhancing social support, or taking the 
drug continuously irrespective of symptoms. Individual patients may respond better to either 
the interactive or didactic approach. 
It is difficult to identify other research that has similar overall findings, in part because of the 
novelty of this approach. However, what we found had face validity. In particular, the 
correspondence between effective and ineffective interventions was often mirror opposites. 
This was best illustrated by the suggestion that the intervention should focus on personal risk 
factors, which was present in most of the effective interventions and absent in all ineffective 
interventions. These findings generate hypotheses about what may be more usefully included 
in future interventions, which then need to be followed by randomised controlled trials to 
generate evidence about effectiveness. 
Limitations and advantages 
There are challenges to the use of QCA as used in this study in the evaluation of 
interventions. These make interpretation of our findings more difficult. First, prior to QCA 
analysis, selection and processing of the evidence from source to our analysis involved the 
need for several decisions. As the focus of this study was on the exploratory use of QCA, our 
search for QES was not exhaustive. We used only controlled vocabulary and a limited 
number of databases. This presupposes that there are more QES beyond those located, from 
any further QES there may be other ways to promote adherence. There were several stages of 
synthesis, extraction and interpretation, with only the final stages undertaken by us. For the 
qualitative evidence this involved: (1) patients’ views on living with and managing a disease 
being collected and analysed in a large number of studies; (2) the findings from these studies 
being pooled in further qualitative analysis, which used different methodologies in critiquing 
and analysing; and (3) these findings then being translated into suggestions for intervention 
components. In the quantitative evidence, the method was challenged by reliance on the 
completeness of intervention descriptions. Complex interventions are often poorly described 
in main trial papers and this is a real limitation to any attempt (using QCA or another 
method) to understand why variations in effectiveness occur. The brevity of descriptions of 
the intervention and the lack of agreement over what constitutes a complete description make 
it problematic to assume that particular aspects of an intervention were absent simply because 
they were unreported. Another limitation in our work is using a P value to decide whether or 
not an intervention was effective or not. However, wherever possible, we used robust 
approaches to reduce the risk of bias, such as by setting quality criteria, and making 
independent checks of steps undertaken during the study. 
In our use of QCA we also needed to make subjective decisions that could have introduced 
error. However, we undertook sensitivity analyses to test the consistency of our findings. In 
QCA a limited number of factors can be analysed and this restricted our exploration of 
heterogeneity of interventions to less than ten features. Additionally, within any one (QCA) 
analysis, the exploration of an outcome can only be conducted in one direction (either the 
outcome is effective or ineffective). A single analysis cannot be used to quantify and compare 
head to head the differences between the outcomes. The method also does not incorporate a 
statistical (probability) measure of the precision of the relationships found in the data, or the 
likelihood that they are simply chance findings. However, the small dataset limits the use of 
conventional statistics and thus alternative approaches are needed. Finally, QCA is only of 
use in circumstances where the trial evidence continues to result in equivocal results. Thus 
not all interventions have the potential to undergo this sort of analysis. 
This case study illustrates the potential for QCA to address a key challenge in trials of 
complex interventions, namely understanding why some are effective and others not. It is 
particularly useful where the pathways (as in complex interventions) to success may differ 
across trials. Using QCA to analyse complex healthcare interventions could identify several 
types of best practice; that is, effective interventions that share similar key components. 
Thereby planners and practitioners may be informed by patient choice to select intervention 
components for a type of best practice based on local conditions and choice. This is with an 
understanding of which components it may be more important to include. 
QCA is under-explored and its usefulness in complex intervention development is not 
established. This study does not suggest that this approach may be useful in every 
circumstance, or that QCA is more informative than other approaches being considered. 
Moreover, there is value in consulting patients directly in the development of an intervention 
[46]. While the results of local consultation apply to the specific setting, they also shed light 
on implications of the intervention elsewhere and the need for consideration of recipients’ 
views and behaviours. For instance, Atkins and colleagues [47] explored patients’ 
experiences of a new intervention, aiming to empower them to take more responsibility for 
the management of their tuberculosis. They found that the intervention had achieved its aims 
but only in patients internalising the intervention messages, not necessarily resulting in an 
increase adherence. 
This paper highlights the value of listening to patients’ views in order to understand disease 
management. In the case of chronic disease, greater adherence seems to be associated with a 
focus on personal risk factors, an emphasis on the value of adherence, and the provision of 
clear and appropriate information on how to adhere. We have demonstrated the potential 
value of using qualitative research to explain the varying effectiveness of complex 
interventions. We call for more integrative research in this area. 
The usefulness of QCA should be tested by comparing it with alternative approaches such as 
using more subjective researcher judgments in exploring the same evidence, or (dependent on 
data limitations) with other analytical tools such as such as Bayesian statistics or regression 
methods. The 10 factors (listed in Table 1) that were mentioned in three or fewer 
interventions and omitted from the analysis may deserve further attention from primary 
research. 
Conclusion 
In this case study, we found that the application of QCA enhanced our understanding of the 
effectiveness of complex interventions. 
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